Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/29530
Title: MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro
Authors: Cerutti, C
Soblechero-Martin, P
Wu, D
Lopez-Ramirez, MA
de Vries, H
Sharrack, B
Male, DK
Romero, IA
Keywords: blood–brain barrier;cell adhesion molecules;flow shear stress;leukocyte adhesion;microRNA‑155;neuroinflammation
Issue Date: 31-May-2016
Publisher: BioMed Central (part of Springer Nature)
Citation: Cerutti, C. et al. (2016) 'MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro', Fluids and Barriers of the CNS, 2016, 13 (1), 8, pp. 1 - 7. doi: 10.1186/s12987-016-0032-3.
Abstract: Background: Increased leukocyte adhesion to brain endothelial cells forming the blood-brain barrier (BBB) es sprecedes extravasation into the central nervous system (CNS) in neuroinflammatory diseasuch as multiple sclerosis (MS). Previously, we reported that microRNA-155 (miR-155) is up-regulated in MS and by inflammatory cytokines in human brain endothelium, with consequent modulation of endothelial paracellular permeability. Here, we investigated the role of endothelial miR-155 in leukocyte adhesion to the human cerebral microvascular endothelial cell line, hCMEC/D3, under shear forces mimicking blood flow in vivo. Results: Using a gain- and loss-of-function approach, we show that miR-155 up-regulation increases leukocyte firm adhesion of both monocyte and T cells to hCMEC/D3 cells. Inhibition of endogenous endothelial miR-155 reduced monocytic and T cell firm adhesion to naïve and cytokines-induced human brain endothelium. Furthermore, this effect is partially associated with modulation of the endothelial cell adhesion molecules VCAM1 and ICAM1 by miR-155. Conclusions: Our results suggest that endothelial miR-155 contribute to the regulation of leukocyte adhesion at the inflamed BBB. Taken together with previous observations, brain endothelial miR-155 may constitute a potential molecular target for treatment of neuroinflammation diseases.
Description: Additional files are available online at: https://fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-016-0032-3#Sec13 .
URI: https://bura.brunel.ac.uk/handle/2438/29530
DOI: https://doi.org/10.1186/s12987-016-0032-3
Other Identifiers: ORCiD: Camilla Cerutti https://orcid.org/0000-0001-9426-686X
8
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright .© 2016 The Author(s). Rights and permissions: Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.1.89 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons